Study to Validate the French Version of the Alcohol Withdrawal Risk Scale PAWSS in Adults with Alcohol Use Disorders
Led by Etablissement Public de Santé Barthélemy Durand · Updated on 2025-02-25
545
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the French version of the Prediction of Alcohol Withdrawal Severity Scale PAWSS in adults with Alcohol Use Disorders AUD. This observational study aims to validate whether the French version has similar psychometric properties to the original English scale. The PAWSS helps predict the risk of complicated alcohol withdrawal, such as seizures or delirium tremens, which can occur during hospital stays when alcohol consumption stops abruptly.
Participants are hospitalized adults aged 18 to 60 with moderate to severe AUD who understand French and are affiliated with the social security system. Participants are followed for three days during their hospital stay. On the first day, they provide consent and clinical data, complete surveys including DSM-5 AUD criteria, AUDIT, the French PAWSS twice by two investigators, and the CIWA-AR scale every 8 hours. On days two and three, the CIWA-AR scale is administered every 8 hours to monitor withdrawal symptoms.
During the study, participants complete several questionnaires and scales to assess alcohol withdrawal severity and risk. Researchers measure the psychometric qualities of the French PAWSS and its ability to predict complicated withdrawal, determine the optimal cutoff score, and evaluate benzodiazepine use. The study includes close monitoring of withdrawal symptoms with regular assessments over three days. Participation involves hospital stay assessments and completion of validated scales to support safer withdrawal management.
CONDITIONS
Brief Title
Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)
Research Team
A
Adelaide Aduayi
M
Manon Bayle--berard
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosis of alcohol use disorder based on DSM-5 criteria
Hospitalized for scheduled alcohol withdrawal or hospitalized for another reason with alcohol use disorder
Ability to understand French
Affiliated with the French social security system
Provided written consent to participate in the study
You will not qualify if you...
Transferred from other hospital services where withdrawal treatment may have already started
Scheduled for discharge within 48 hours
Known uncontrolled epilepsy
Unable to understand the questionnaire
Unable to provide consent or not volunteering for the study
Under guardianship or curatorship
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - 3 days
Participants complete the French version of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) and related assessments during hospitalization to evaluate alcohol withdrawal risk.
Daily visits with assessments every 8 hours during hospitalization for 3 days
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Phase 1 Study Comparing IVL3004 and IVL4002 to Vivitrol4 Naltrexone Long-Acting Injection in Healthy Adult Males
Testing Combined Neurofeedback and TMS Treatments for Alcohol Use Disorder in Adults Aged 19 to 65
Study of CMND-100 Safety, Dosing, and Effects in Healthy Adults and Adults With Alcohol Use Disorder
Evaluating a New Blood Test to Help Diagnose and Monitor Depression and Psychosis in Adults
Evaluating Peer Recovery Coaching for Adults Hospitalized with Alcohol Use Disorder to Support Long-Term Recovery and Reduce Heavy Drinking
Study of Brain Stimulation to Enhance Motivational Interviewing for Adults Who Drink Alcohol at Risky Levels
Study Comparing Digital Avatar-Assisted CBT and Standard Face-to-Face CBT
for Treating Addiction and Intimate Partner Violence in Men Aged 18 to 65
Adaptive Web-Based Treatments for Alcohol Use in Military Spouses and Service Members Evaluating Partners Connect and CRAFT Interventions
Phase 3 Study Comparing Brenipatide With Placebo for Adults With Alcohol Use Disorder to Evaluate Efficacy and Safety
Phase 3 Study of Brenipatide Versus Placebo for Adults With Moderate-to-Severe Alcohol Use Disorder Assessing Efficacy and Safety
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS): systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome.
José R Maldonado, Yelizaveta Sher, Judith F Ashouri...
Prospective Validation Study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in Medically Ill Inpatients: A New Scale for the Prediction of Complicated Alcohol Withdrawal Syndrome.